Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.


Journal

Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 10 10 2019
medline: 10 9 2020
entrez: 10 10 2019
Statut: ppublish

Résumé

People with type 1 diabetes (T1D) have varying sensitivities to insulin and also varying responses to meals and exercise. We introduce a new adaptive run-to-run model predictive control (MPC) algorithm that can be used to help people with T1D better manage their glucose levels using an artificial pancreas (AP). The algorithm adapts to individuals' different insulin sensitivities, glycemic response to meals, and adjustment during exercise as a continuous input during free-living conditions. A new insulin sensitivity adaptation (ISA) algorithm is presented that updates each patient's insulin sensitivity during nonmeal periods to reduce the error between the actual glucose levels and the process model. We further demonstrate how an adaptive learning postprandial hypoglycemia prevention algorithm (ALPHA) presented in the previous work can complement the ISA algorithm, and the algorithm can adapt in several days. We further show that if physical activity is incorporated as a continuous input (heart rate and accelerometry), performance is improved. The contribution of this work is the description of the ISA algorithm and the evaluation of how ISA, ALPHA, and incorporation of exercise metrics as a continuous input can impact glycemic control. Incorporating ALPHA, ISA, and physical activity into the MPC improved glycemic outcome measures. The adaptive learning postprandial hypoglycemia prevention algorithm combined with ISA significantly reduced time spent in hypoglycemia by 71.7% and the total number of rescue carbs by 67.8% to 0.37% events/day/patient. Insulin sensitivity adaptation significantly reduced model-actual mismatch by 12.2% compared to an AP without ISA. Incorporating physical activity as a continuous input modestly improved time in the range 70 to 180 mg/dL during high physical activity days from 84.4% to 84.9% and reduced the percentage time in hypoglycemia by 23.8% from 2.1% to 1.6%. Adapting postprandial insulin delivery, insulin sensitivity, and adapting to physical exercise in an MPC-based AP systems can improve glycemic outcomes.

Sections du résumé

BACKGROUND
People with type 1 diabetes (T1D) have varying sensitivities to insulin and also varying responses to meals and exercise. We introduce a new adaptive run-to-run model predictive control (MPC) algorithm that can be used to help people with T1D better manage their glucose levels using an artificial pancreas (AP). The algorithm adapts to individuals' different insulin sensitivities, glycemic response to meals, and adjustment during exercise as a continuous input during free-living conditions.
METHODS
A new insulin sensitivity adaptation (ISA) algorithm is presented that updates each patient's insulin sensitivity during nonmeal periods to reduce the error between the actual glucose levels and the process model. We further demonstrate how an adaptive learning postprandial hypoglycemia prevention algorithm (ALPHA) presented in the previous work can complement the ISA algorithm, and the algorithm can adapt in several days. We further show that if physical activity is incorporated as a continuous input (heart rate and accelerometry), performance is improved. The contribution of this work is the description of the ISA algorithm and the evaluation of how ISA, ALPHA, and incorporation of exercise metrics as a continuous input can impact glycemic control.
RESULTS
Incorporating ALPHA, ISA, and physical activity into the MPC improved glycemic outcome measures. The adaptive learning postprandial hypoglycemia prevention algorithm combined with ISA significantly reduced time spent in hypoglycemia by 71.7% and the total number of rescue carbs by 67.8% to 0.37% events/day/patient. Insulin sensitivity adaptation significantly reduced model-actual mismatch by 12.2% compared to an AP without ISA. Incorporating physical activity as a continuous input modestly improved time in the range 70 to 180 mg/dL during high physical activity days from 84.4% to 84.9% and reduced the percentage time in hypoglycemia by 23.8% from 2.1% to 1.6%.
CONCLUSION
Adapting postprandial insulin delivery, insulin sensitivity, and adapting to physical exercise in an MPC-based AP systems can improve glycemic outcomes.

Identifiants

pubmed: 31595784
doi: 10.1177/1932296819881467
pmc: PMC6835177
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1044-1053

Subventions

Organisme : NIDDK NIH HHS
ID : DP3 DK101044
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK120367
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002369
Pays : United States

Références

Diabetes Technol Ther. 2014 Aug;16(8):506-11
pubmed: 24702135
IEEE Trans Biomed Eng. 2018 Mar;65(3):479-488
pubmed: 28092515
J Diabetes Sci Technol. 2009 Sep 01;3(5):1031-8
pubmed: 20144416
J Diabetes Sci Technol. 2015 Oct 05;9(6):1175-84
pubmed: 26438720
Diabetes. 1983 Apr;32(4):331-6
pubmed: 6339306
J Appl Physiol (1985). 2008 Jun;104(6):1665-73
pubmed: 18403453
Diabetes Technol Ther. 2013 May;15(5):386-400
pubmed: 23544672
Comput Methods Programs Biomed. 2017 Jul;146:125-131
pubmed: 28688482
IEEE Trans Biomed Eng. 2014 Oct;61(10):2569-81
pubmed: 24835122
J Diabetes Sci Technol. 2010 Sep 01;4(5):1174-81
pubmed: 20920437
PLoS One. 2019 Jul 25;14(7):e0217301
pubmed: 31344037
Physiol Meas. 2004 Aug;25(4):905-20
pubmed: 15382830
Can J Diabetes. 2019 Aug;43(6):406-414.e1
pubmed: 30414785
J Diabetes Sci Technol. 2007 Nov;1(6):804-12
pubmed: 19885152
Sensors (Basel). 2017 Mar 07;17(3):
pubmed: 28272368
IEEE Trans Biomed Eng. 1999 Feb;46(2):148-57
pubmed: 9932336
ASAIO J. 2000 Nov-Dec;46(6):657-62
pubmed: 11110261
Proc IEEE Conf Decis Control. 2015 Dec;2015:3834-3839
pubmed: 26997750
Diabetes Care. 2018 Jul;41(7):1471-1477
pubmed: 29752345
Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:2270-2273
pubmed: 28324962
J Diabetes Sci Technol. 2017 May;11(3):537-544
pubmed: 28745095
J Diabetes Sci Technol. 2009 Sep 01;3(5):1091-8
pubmed: 20144422
Diabetes Obes Metab. 2016 Nov;18(11):1110-1119
pubmed: 27333970
Am J Physiol. 1999 Sep;277(3):E481-8
pubmed: 10484360
Lancet Diabetes Endocrinol. 2017 May;5(5):377-390
pubmed: 28126459

Auteurs

Navid Resalat (N)

Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.

Wade Hilts (W)

Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.

Joseph El Youssef (JE)

Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon Health & Science University, Portland, OR, USA.

Nichole Tyler (N)

Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.

Jessica R Castle (JR)

Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon Health & Science University, Portland, OR, USA.

Peter G Jacobs (PG)

Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH